ANG Lifesciences India Limited Share Price

₹ 32.50

+₹0.41 (1.28%)
1D
Last updated 02 Nov, 2026, 15:29 IST
BSE: 540694
|
Pharmaceuticals

ANG Lifesciences India Limited Share Price Today

As of 2 Nov 2026, ANG Lifesciences India Limited share price is ₹32.50. The stock opened at ₹32.09, compared to its previous close of ₹32.09. During today's trading session, ANG Lifesciences India Limited share price moved in the range of ₹31.00 to ₹34.50, with an average price of ₹32.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹17.63 and a high of ₹49.69.

Share price over the last 1 day rose from 32.09 to 32.50, ranging between 31.00 and 34.50.
₹31.00
1.28% up today
₹34.50
1D LOW
1D HIGH

ANG Lifesciences India Limited Stock Insights

Latest Earning
Op Profit TrendUp by 17.13% YoY
Latest Earning
Net Profit TrendUp by 10.72% YoY
Latest Earning
Revenue TrendDown by 34.90% QoQ
Stock Performance
OutperformingBeat Nifty by 18.62 % in last 6 month
ANG Lifesciences India Limited stock performance
Open₹32.09
High₹34.50
Low₹31.00
Prev. close₹32.09
ANG Lifesciences India Limited trading activity
Volume2,769
Average traded price₹32.86
Last traded time03:29:19 02 Nov
Last traded quantity130
Circuit
L
H
₹25.68
₹38.50
52-week
L
H
₹17.63
₹49.69
Mkt Cap Cr
41.90
P/E
-3.15
P/B
0.87
ROA
-6.37%
ROE
-20.96%
ROCE
-3.83%
Quick Ratio
0.69
EV/EBITDA
-87.7

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
ANG Lifesciences has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
ANG Lifesciences appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
ANG Lifesciences earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ANG Lifesciences India Limited Company Background

ISIN
INE236W01016
Sector Market Cap
₹ 41.90 Cr

ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packaging. The Company's product portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. The Company’s product category includes Dry Powder Injection, Liquid Injections, Hard Gelatin Capsule, Tablet Beta Lactum, Tablets, Liquid Suspension /Syrup, Ointment/Creams, and Soft Gelatin Capsule. Its Dry Powder Injection products include Ampicillin & Cloxacillin for injection 500mg, Azetronam for Injection USP 500mg, Ampicillin Injection 1.0gm, Ceftriaxone Injection 250mg, Amoxycillin & Potassium Clavulanate for injection 1.2gm, and others.

ANG Lifesciences India Limited Financial Highlights

  • Revenue: ANG Lifesciences India Limited reported revenue of ₹93.43 crore in FY26 vs ₹94.86 crore in FY25. It showed a decrease of 1.51% on a yearly basis.
  • Operating Profit: ANG Lifesciences India Limited reported an operating loss of ₹13.01 crore in FY26 vs ₹15.70 crore in FY25. It showed an increase of 17.13% on a year-on-year basis.
  • Net Profit: ANG Lifesciences India Limited reported a net loss of ₹11.08 crore in FY26 vs ₹12.41 crore in FY25. It showed an increase of 10.72% on a yearly basis.

ANG Lifesciences India Limited Quarterly Result Highlights

  • ANG Lifesciences India Limited reported revenue of ₹15.41 crore in Jun 2026, compared with ₹23.67 crore in Mar 2026, representing a decrease of 34.90% on a quarter-on-quarter (QoQ) basis.
  • ANG Lifesciences India Limited reported an operating loss of ₹5.58 crore in Jun 2026, compared with ₹1.10 crore in Mar 2026, representing a decrease of 407.27% on a quarter-on-quarter (QoQ) basis.
  • ANG Lifesciences India Limited reported a loss of ₹4.24 crore in Jun 2026, compared with ₹1.38 crore in Mar 2026, reflecting a decrease of 207.25% on a QoQ basis.
  • The earnings per share (EPS) of ANG Lifesciences India Limited stood at ₹8.43 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
70.60%
FII
0.00%
Other DII
0.00%
Retail and other
29.40%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

ANG Lifesciences India Limited Investment Returns

1 day
+2.43%
1 week
+0.09%
1 month
-18.19%
1 year
+5.96%
3 years
-52.13%
5 years
-93.77%

ANG Lifesciences India Limited Share Price History

ANG Lifesciences India Limited share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹36.00 / ₹32.09
-6.72%
29 Oct 26
₹33.66 / ₹34.40
+2.69%
28 Oct 26
₹34.38 / ₹33.50
+0.36%
27 Oct 26
₹39.00 / ₹33.38
+1.64%
Show more

ANG Lifesciences India Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹92.89₹92.85₹146.11₹219.89
Other Income₹0.54₹2.02₹0.70₹9.72
Total Revenue₹93.44₹94.87₹146.81₹229.61
Total Expenses₹106.45₹110.57₹155.79₹226.99
Profit Before Tax-₹13.01-₹15.70-₹10.71₹2.63
Tax-₹1.93-₹3.29-₹0.57₹2.89
Profit After Tax-₹11.08-₹12.41-₹10.14-₹0.26
EPS - Basic-₹8.43-₹9.42-₹7.61₹0.36
EPS - Diluted-₹8.43-₹9.42-₹7.61₹0.36

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹13.01-₹15.70-₹10.71₹2.63
Income before WC changes₹2.53-₹2.25₹9.18₹23.32
Change in Assets₹14.25₹9.72₹10.86₹7.05
Change in Liabilities-₹5.70-₹3.50-₹16.12-₹0.53
Change in WC₹8.54₹6.22-₹5.27₹6.51
Cash flow from Operations₹11.03-₹0.26-₹9.49₹26.38
Cash flow from Investing₹1.05-₹1.59₹19.89-₹9.33
Cash flow from Financing-₹11.74₹1.68-₹10.40-₹17.07
Total Cash Flow₹0.34-₹0.16-₹0.01-₹0.02
Cash (Start of the year)₹0.16₹0.32₹0.32₹0.35
Cash (End of the year)₹0.49₹0.16₹0.32₹0.32

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹59.59₹64.25₹69.13₹94.51
Current Assets₹149.35₹165.34₹173.31₹183.15
Total Assets₹208.95₹229.59₹242.44₹277.66
Current Liabilities₹149.04₹143.44₹144.57₹162.28
Net Current Asset₹0.32₹21.90₹28.75₹20.87
Non-Current Liabilities₹7.02₹22.18₹21.59₹29.16
Equity Capital₹52.89₹63.98₹76.28₹86.22
Total Equity & Liabilities₹208.95₹229.59₹242.44₹277.66

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹91.60₹89.91₹131.37₹207.01
Other Income₹0.73₹2.44₹0.84₹9.84
Total Revenue₹92.33₹92.35₹132.20₹216.85
Total Expenses₹97.52₹105.29₹139.34₹214.78
Profit Before Tax-₹5.19-₹12.94-₹8.87₹2.07
Tax-₹0.46-₹2.59-₹0.22₹2.73
Profit After Tax-₹4.73-₹10.34-₹8.65-₹0.66
EPS - Basic-₹3.52-₹7.86-₹6.48₹0.04
EPS - Diluted-₹3.52-₹7.86-₹6.48₹0.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹5.19-₹12.94-₹8.87₹2.07
Income before WC changes₹7.06-₹1.19₹8.59₹20.40
Change in Assets₹13.30₹9.41₹8.29₹12.72
Change in Liabilities-₹6.58-₹6.33-₹16.61-₹3.76
Change in WC₹6.71₹3.09-₹8.32₹8.96
Cash flow from Operations₹13.72-₹2.29-₹13.13₹26.01
Cash flow from Investing-₹3.33-₹1.63₹20.02-₹9.35
Cash flow from Financing-₹10.19₹3.92-₹7.00-₹16.75
Total Cash Flow₹0.20-₹0.01-₹0.12-₹0.08
Cash (Start of the year)₹0.08₹0.09₹0.20₹0.29
Cash (End of the year)₹0.28₹0.08₹0.09₹0.20

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹52.71₹57.87₹59.05₹84.30
Current Assets₹137.20₹150.80₹158.37₹168.21
Total Assets₹189.91₹208.67₹217.43₹252.51
Current Liabilities₹124.58₹125.37₹125.90₹146.36
Net Current Asset₹12.63₹25.43₹32.48₹21.85
Non-Current Liabilities₹3.12₹16.49₹14.46₹20.62
Equity Capital₹62.22₹66.81₹77.07₹85.54
Total Equity & Liabilities₹189.91₹208.67₹217.43₹252.51
* All values are in INR Crore
ANG Lifesciences India Limited market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
ANG Lifesciences India Limited technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
38.05
Neutral
ATR (14)
3.84
Neutral
STOCH(9,6)
42.35
Neutral
STOCH RSI (14)
22.44
Neutral
ADX(9)
53.69
Bearish
UO(9)
30.44
Neutral
ROC(12)
-2.19
Bearish
WillR(14)
-57.65
Neutral
Period
Simple value
Exponential vaue
5D
33.24
33.35
10D
34.48
34.08
20D
35.61
35.01
50D
34.73
34.99
100D
34.16
33.54
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

ANG Lifesciences India Limited
Pharmaceuticals
Add Stock
Add Another

ANG Lifesciences India Limited Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

ANG Lifesciences India Limited Share Price FAQs

Please be aware that ANG Lifesciences India Limited stock prices are subject to continuous fluctuations due to various factors.